Peptide-mediated interactions in biological systems: new discoveries and applications

Current Opinion in Biotechnology

Volumn 19, Issue 4, 2008, Pages 344-350

  Petsalaki, Evangelia ^a   Russell, Robert B ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOLOGICAL SYSTEMS; FLOW INTERACTIONS; HEALTH; MOLECULAR BIOLOGY; MOLECULAR INTERACTIONS;

BIOACTIVE PEPTIDES; BIOLOGY AND MEDICINE; CELLULAR PROCESSES; NUMEROUS APPLICATIONS; PEPTIDE-BINDING; PROTEIN-PEPTIDE INTERACTIONS;

AMINES;

ALPHA SYNUCLEIN; ATM PROTEIN; GLYCOPROTEIN E2; PEPTIDE; PODOPHYLLOTOXIN; PROTEIN E7; PROTEIN P53; PROTEIN SH3;

ACCURACY; BINDING SITE; CD4+ T LYMPHOCYTE; CELL FUNCTION; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVE SITE; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

MODELS, MOLECULAR; PEPTIDES; PROTEIN CONFORMATION; PROTEINS;

EID: 49549083915     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2008.06.004     Document Type: Review

References (46)

1. Dyson J.H., and Wright P.E. Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 6 3 (2005) 197-208
2. Dunker AK, Obradovic Z, Romero, Garner EC, Brown CJ: Intrinsic Protein Disorder in Complete Genomes. Genome Inform Ser Workshop Genome Inform 2000, 11:161-71.
3. Diella F., Haslam N., Chica C., Budd A., Michael S., Brown N.P., Trave G., and Gibson T.J. Understanding eukaryotic linear motifs and their role in cell signaling and regulation. Front Biosci 13 (2008) 6580-6603
4. Remaut H., and Waksman G. Protein-protein interaction through β-strand addition. TIBS 31 8 (2006) 436-444
5. Pawson T., and Scott J.D. Signaling through scaffold, anchoring, and adaptor proteins. Science 278 5346 (1997) 2075-2080
6. Vagner J., Qu H., and Hruby V.J. Peptidomimetics, a synthetic tool of drug discovery. Curr Opin Chem Biol 12 (2008) 1-5
7. Neduva V., and Russell R.B. Peptides mediating interaction networks: new leads at last. Curr Opin Biotechnol 17 5 (2006) 465-471
8. Tovar C., Rosinski J., Filipovic Z., Higgins B., Kolinsky K., Hilton H., Zhao X., Vu B.T., Qing W., Packman K., et al. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Proc Natl Acad Sci U S A 103 6 (2006) 1888-1893
9. Vassilev L.T., Vu B.T., Graves B., Carvajal D., Podlaski F., Filipovic Z., Kong N., Kammlott U., Lukacs C., Klein C., et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303 5659 (2004) 844-848
10. Ceol A., Chatr-aryamontri A., Santonico E., Sacco R., Castagnoli L., and Cesareni G. DOMINO: a database of domain-peptide interactions. Nucleic Acids Res 35 Database issue (2007) D557-D560. DOMINO is an open-access database that contains manually annotated experimentally verified instances of protein-peptide interacting pairs.
11. Hubbard T, Andrews D, Caccamo M, Cameron G, Chen Y, Clamp M, Clarke L, Coates G, Cox T, Cunningham F, et al.: Ensembl 2005. Nucleic Acids Research 2005, 33 (Database Issue):D447-D453.
12. Li S.S. Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction. Biochem J 390 (2005) 641-653
13. Russell R.B., and Gibson T.J. A careful disorderliness in the proteome: Sites for interaction and targets for future therapies. FEBS Lett (2008)
14. Mering v.C., Jensen L.J., Snel B., Hooper S.D., Krupp M., Foglierini M., Jouffre N., Huynen M.A., and Bork P. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids (2005) Res 33
15. Puntervoll P., Linding R., Gemünd C., Chabanis-Davidson S., Mattingsdal M., Cameron S., Martin D.M., Ausiello G., Brannetti B., Costantini A., et al. ELM server: a new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Res 31 13 (2003) 3625-3630
16. Diella F., Cameron S., Gemünd C., Linding R., Via A., Kuster B., Sicheritz-Pontén T., Blom N., and Gibson T.J. Phospho.ELM: a database of experimentally verified phosphorylation sites in eukaryotic proteins. BMC Bioinform 22 5 (2004) 79
17. Manning G., Whyte D.B., Martinez R., Hunter T., and Sudarsanam S. The protein kinase complement of the human genome. Science 298 (2002) 1912-1934
18. Neduva V., Linding R., Su-Angrand I., Stark A., Masi F.D., Gibson T.J., Lewis J., Serrano L., and Russell R.B. Systematic discovery of new recognition peptides mediating protein interaction networks. PLoS Biol 3 12 (2005)
19. Till S., Lejeune E., Thermann R., Bortfeld M., Hothorn M., Enderle D., Heinrich C., Hentze M.W., and Ladurner A.G. A conserved motif in Argonaute-interacting proteins mediates functional interactions through the Argonaute PIWI domain. Nat Struct Mol Biol 14 10 (2007) 897-903. This paper describes a peptide motif that binds to the PIWI domain of Argonaute protein and disrupts heterochromatin silencing. The authors suggest that other proteins containing the motif might also function as regulators of RNA interference.
20. Kim JE, Chen J, Lou Z: DBC1 is a negative regulator of SIRT1. Nature 451:583-586.
21. Bi X., Mancias J.D., and Goldberg J. Insights into COPII coat nucleation from the structure of Sec23-Sar1 complexed with the active fragment of Sec31. Dev Cell 13 5 (2007) 635-645. This paper describes the structure of the Sec23/Sar1 protein bound to a 40 residue peptide from Sec31 enabling the formation of the Sec23/Sec24-Sar1 complex and recruitment of Sec13/31 to the membrane of the endoplasmic reticulum. A mutation which disrupts peptide binding prevents the nucleation of COPII coat proteins and causes cranio-lenticulo-sutural dysplasia.
22. Balla S., Thapar V., Verma S., Luong T., Faghri T., Huang C., Rajasekaran S., del Campo J., Shinn J.H., Mohler W.A., et al. Minimotif Miner: a tool for investigating protein function. Nat Methods 3 3 (2006) 175-177
23. Obenauer J.C., Cantley L.C., and Yaffe M.B. Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 31 13 (2003) 3635-3641
24. Amanchy R., Periaswamy B., Mathivanan S., Reddy R., Tattikota S.G., and Pandey A. A curated compendium of phosphorylation motifs. Nat Biotechnol 25 3 (2007) 285-286
25. Shtatland T., Guettler D., Kossodo M., Pivovarov M., and Weissleder R. PepBank - a database of peptides based on sequence text mining and public peptide data sources. BMC Bioinform 8 (2007) 280
26. Wang Z., and Wang G. APD: the antimicrobial peptide database. Nucleic Acids Res 32 (2004) D590-D592
27. Valuev V.P., Afonnikov D.A., Ponomarenko M.P., Milanesi L., and Kolchanov N.A. ASPD (artificially selected proteins-peptides database): a database of proteins and peptides evolved in vitro. Nucleic Acids Res 30 1 (2002) 200-202
28. Zhang X., Pickin K.A., Bose R., Jura N., Cole P.A., and Kuriyan J. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 450 7170 (2007) 741-744. This paper describes the identification of a 25 residue peptide from MIG6 that binds to the kinase domain of epidermal growth factor receptors and inhibits the formation of the active dimer required for function.
29. Tong A.H., Drees B., Nardelli G., Bader G.D., Brannetti B., Castagnoli L., Evangelista M., Ferracuti S., Nelson B., Paoluzi S., et al. A combined experimental and computational strategy to define protein interaction networks for peptide recognition modules. Science 295 5553 (2002) 321-324
30. Elia A.E., Cantley L.C., and Yaffe M.B. Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates. Science 299 5610 (2003) 1228-1231
31. Edwards R.J., Moran N., Devocelle M., Kiernan A., Meade G., Signac W., Foy M., Park S.D., Dunne E., Kenny D., et al. Bioinformatic discovery of novel bioactive peptides. Nat Chem Biol 3 2 (2007) 108-112. Here many novel bioactive peptides in platelet function are found using a bioinformatic approach. The authors use information only about the proteins in the system and the conservation of the proteins under study. Tests in in vivo assays show that several of the predicted peptides have platelet modulating activity.
32. Neduva V., and Russell R.B. DILIMOT: discovery of linear motifs in proteins. Nucleic Acids Res 34 Web Server Issue (2006) W350-W355
33. Edwards R.J., Davey N.E., and Shields D.C. SLiMFinder: a probabilistic method for identifying over-represented, convergently evolved, short linear motifs in proteins. PLoS ONE 3 2 (2007) e967
34. Davey N.E., Shields D.C., and Edwards R.J. SLiMDisc: short, linear motif discovery, correcting for common evolutionary descent. Nucleic Acids Res 34 12 (2006) 3546-3554
35. Tan S.H., Hugo W., Sung W.K., and Ng S.K. A correlated motif approach for finding short linear motifs from protein interaction networks. BMC Bioinform 7 (2006) 502
36. Linding R., Jensen L.J., Ostheimer G.J., van Vugt M.A., Jørgensen C., Miron I.M., Diella F., Colwill K., Taylor L., Elder K., et al. Systematic discovery of in vivo phosphorylation network. Cell 129 7 (2007) 1415-1426. Here, non-specific kinase phosphorylation site motifs and contextual information from interaction networks are used to predict kinase phosphorylation sites with great accuracy. The authors predict and validate several predictions of phosphorylation sites within DNA damage and repair processes.
37. Nielsen M., Lundegaard C., Blicher T., Lamberth K., Harndahl M., Justesen S., Røder G., Peters B., Sette A., Lund O., et al. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS ONE 8 (2007) e796
38. Brannetti B., Via A., Cestra G., Cesareni G., and Helmer-Citterich M. SH3-SPOT: an algorithm to predict preferred ligands to different members of the SH3 gene family. J Mol Biol 298 2 (2000) 313-328
39. Betel D., Breitkreuz K.E., Isserlin R., Dewar-Darch D., Tyers M., and Hogue C.W. Structure-templated predictions of novel protein interactions from sequence information. PLoS Comput Biol 3 9 (2007) 1783-1789. This paper presents a method to predict new interaction partners for proteins where protein/protein complex structures are available. The authors perform a 3D structural analysis from known domain-domain, domain-peptide interactions and create binding profiles for each domain. They then search for these binding profiles on other protein sequences to identify new interacting partners.
40. Chen X., Longgood J.C., Michnoff C., Wei S., Frantz D.E., and Bezprozvanny L. High-throughput screen for small molecule inhibitors of Mint1-PDZ domains. Assay Drug Dev Technol 5 6 (2007) 769-783
41. Saitoh T., Kuramochi K., Imai T., Takata K.I., Takehara M., Kobayashi S., Sakaguchi K., and Sugawara F. Podophyllotoxin directly binds a hinge domain in E2 of HPV and inhibits an E2/E7 interaction in vitro. Bioorg Med Chem 16 10 (2008) 5815-5825 10.1016/j.bmc.2008.03.053.2008
42. Longo F.M., and Massa S.M. Small molecule modulation of p75 neurotrophin receptor functions. CNS Neurol Disord Drug Targets 7 1 (2008) 63-70
43. Jouaux E.M., Schmidtkunz K., Müller K.M., and Arndt K.M. Targeting the c-Myc coiled coil with interfering peptides. J Pept Sci (2008) 10.1002/psc.1038
44. Watt P.M. Screening for peptide drugs from the natural repertoire of biodiverse protein folds. Nat Biotechnol 24 2 (2006) 177-183
45. Matthews T., Salgo M., Greenberg M., Chung J., DeMasi R., and Bolognesi D. Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes. Nat Rev Drug Discov 3 3 (2004) 215-225
46. Kanehisa M., Araki M., Goto S., Hattori M., Hirakawa M., Itoh M., Katayama T., Kawashima S., Okuda S., Tokimatsu T., and Yamanishi Y. KEGG for linking genomes to life and the environment. Nucleic Acids Res 36 Database Issue (2008) D480-D484